[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355216-105":59,"doc-detail-355216-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeting-mir-4653-3pslc25a51sirt3-axis-to-induce-synthetic-lethality-in-arid1a-deficient-colorectal-cancer-via-blockade-of-dna-repair","Targeting miR-4653-3p/SLC25A51/SIRT3 axis to induce synthetic lethality in ARID1A-deficient colorectal cancer via blockade of DNA repair","","ARID1A, a tumor suppressor within the SWI/SNF chromatin remodeling complex, is frequently inactivated across cancers, making ARID1A deficiency a promising therapeutic vulnerability in colorectal cancer. Using high-throughput screening with ARID1A isogenic CRC cell lines, the study identifies a synthetic lethal interaction with miR-4653-3p. miR-4653-3p suppresses proliferation by directly targeting SLC25A51, impairing SIRT3 activity, amplifying DNA damage and promoting apoptosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-mir-4653-3pslc25a51sirt3-axis-to-induce-synthetic-lethality-in-arid1a-deficient-colorectal-cancer-via-blockade-of-dna-repair/355216/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-mir-4653-3pslc25a51sirt3-axis-to-induce-synthetic-lethality-in-arid1a-deficient-colorectal-cancer-via-blockade-of-dna-repair/355216.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the core therapeutic concept tested in this study?","Question",{"text":112,"@type":113},"The study focuses on synthetic lethality, where ARID1A deficiency becomes lethal when combined with inhibition driven by miR-4653-3p targeting the miR-4653-3p/SLC25A51/SIRT3 axis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was miR-4653-3p identified as relevant to ARID1A deficiency?",{"text":117,"@type":113},"A high-throughput screening of a microRNA mimic library was performed using ARID1A isogenic colorectal cancer cell lines, leading to the identification of a synthetic lethal interaction between ARID1A and miR-4653-3p.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism links miR-4653-3p to increased cell death in ARID1A-deficient cells?",{"text":121,"@type":113},"miR-4653-3p directly targets SLC25A51, reducing mitochondrial NAD+ transporter function and impairing SIRT3 enzymatic activity; combined loss of ARID1A and SIRT3 aggravates DNA damage accumulation and promotes apoptosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355216,1790836449,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Lin et al. Journal of Translational Medicine (2026) 24:320  \n[https://doi.org/10.1186/s12967-026-07760-8](https://doi.org/10.1186/s12967-026-07760-8)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nTargeting miR-4653-3p/SLC25A51/SIRT3 axis to induce synthetic lethality in ARID1Adeficient colorectal cancer via blockade of DNA repair  \nXin Lin1, Changjie Wu1, Danzhu Wu1, Wenjie Qin1, Yingyi Zeng1, Yixian Song1, Li Xiang2, Joong Sup Shim3*, Side Liu1* and Aimin Li 1*  \nAbstract  \nBackground ARID1A, a subunit of the SWI/SNF chromatin remodeling complex, functions as a tumor suppressor and is frequently inactivated across various cancer types. Consequently, ARID1A deficiency has emerged as a promising therapeutic target.  \nMethods In this study, we conducted a high-throughput screening of a microRNA (miRNA) mimic library using ARID1A isogenic colorectal cancer (CRC) cell lines and identified a synthetic lethal interaction between ARID1A and miR-4653-3p.  \nResults MiR-4653-3p selectively inhibited the proliferation of ARID1A-deficient CRC cells. Mechanistically, miR- 4653-3p directly targets SLC25A51, a mitochondrial NAD⁺ transporter gene, leading to impaired SIRT3 enzymatic activity. Since both ARID1A and SIRT3 play critical roles in DNA damage repair, their concurrent loss exacerbates DNA damage accumulation and promotes apoptosis.  \nConclusions In conclusion, our findings reveal a novel synthetic lethality between ARID1A and miR-4653-3p, and suggest that targeting the miR-4653-3p/SLC25A51/SIRT3 axis, in combination with agents that disrupt DNA damage response, may offer a promising therapeutic strategy for ARID1A-deficient CRC.  \nKeywords Synthetic lethality, ARID1A, miR-4653-3p, SLC25A51, SIRT3, DNA damage response, Colorectal cancer  \n*Correspondence: Joong Sup Shim [jsshim@um.edu. mo](jsshim@um.edu. mo)[ ](jsshim@um.edu. mo)Side Liu [sideliu@smu.edu.cn](sideliu@smu.edu.cn)[ ](sideliu@smu.edu.cn)Aimin Li[lam0725@smu.edu.cn](lam0725@smu.edu.cn)  \n1Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China  \n2Department of Gastroenterology, The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People’s Hospital of Shenzhen, Shenzhen, China 3Cancer Centre, Faculty of Health Sciences, MOE Frontiers Science Centre for Precision Oncology, University of Macau, Taipa, Macau SAR, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nLin et al. Journal of Translational Medicine (2026) 24:320  \nIntroduction  \nColorectal cancer (CRC) is one of the most prevalent malignancies and a leading cause of cancer-related mortality worldwide [1]. Although targeted therapies have introduced new treatment strategies and improved outcomes for certain patients, significant challenges remain—particularly the","cbCaii9KBE12SztQ","https://ap.wps.com/l/cbCaii9KBE12SztQ","pdf",9136715,15,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the core therapeutic concept tested in this study?\",\"answer\":\"The study focuses on synthetic lethality, where ARID1A deficiency becomes lethal when combined with inhibition driven by miR-4653-3p targeting the miR-4653-3p/SLC25A51/SIRT3 axis.\"},{\"question\":\"How was miR-4653-3p identified as relevant to ARID1A deficiency?\",\"answer\":\"A high-throughput screening of a microRNA mimic library was performed using ARID1A isogenic colorectal cancer cell lines, leading to the identification of a synthetic lethal interaction between ARID1A and miR-4653-3p.\"},{\"question\":\"What mechanism links miR-4653-3p to increased cell death in ARID1A-deficient cells?\",\"answer\":\"miR-4653-3p directly targets SLC25A51, reducing mitochondrial NAD+ transporter function and impairing SIRT3 enzymatic activity; combined loss of ARID1A and SIRT3 aggravates DNA damage accumulation and promotes apoptosis.\"}]","Targeting miR-4653-3p/SLC25A51/SIRT3 axis to induce synthetic lethality in ARID1A-deficient colorectal cancer via blockade of DNA repair | PDF",1790116782,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab2f13188113455b6aba68dd68471470.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a868572b6f71546eb289b81a9dc1945.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5256431be23181fce125be11760464a0.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61db3a2d83ec0e10143593836731a87b.webp",980,1306]